S17I (p.Ser17Ile) variant of JAK3 (Tyrosine-protein kinase JAK3)
S17I (p.Ser17Ile) in JAK3 (Tyrosine-protein kinase JAK3) is a missense change. Clinical records from UniProt describe it as variant assessed as somatic; moderate impact. The record also includes structural context.
S17I (p.Ser17Ile) variant details
- p.Ser17Ile
- NCI-TCGA TCGA novel
- TOPMed rs2094247284
- Variant assessed as somatic; moderate impact.
- Missense
- UniProt: Variant assessed as somatic; moderate impact.
- Structural context available